In addition, ACLY, a key enzyme of de novo fatty acid synthesis, was significantly upregulated in ccRCC tumors (Fig. 4d, Supplementary Fig. 4e). This evidence concerns the gene ACLY and nonpapillary renal cell carcinoma.